Contraceptive Technology Update – October 1, 2010
October 1, 2010
View Issues
-
Use contraception management tips for women approaching menopause
Your next patient is a recently divorced 48-year-old mother of two. Her menstrual periods have become somewhat irregular, and she reports occasional hot flashes and night sweats. -
Add ella to options for emergency contraception
Get ready to add another option to the list of emergency contraception (EC) methods. The Food and Drug Administration has approved ella (ulipristal acetate, UPA) tablets. -
HIV breakthrough: Trial results offer promise
The search for a female-controlled form of HIV prevention just took a giant step. Results of a Phase IIB trial of a tenofovir gel indicate that use of the gel before and after sex provided moderate protection against sexually transmitted HIV. -
Managing recurrent vaginitis: What works?
While vaginitis usually is considered a minor nuisance, many women experience chronic symptoms that persist or recur after treatment. What can clinicians do? -
New research may boost AIDS vaccine search
Good news! Scientists have discovered two potent human antibodies that can neutralize more than 90% of known global HIV strains from infecting human cells in the laboratory, and they have demonstrated how one of these disease-fighting proteins achieves this action.